A comprehensive report on the Mexican Healthcare Life Sciences Industry. The report includes exclusive interviews with Associations, Regulators, Heads of Multinational and Local Companies, Manufacturers, Distributors and Consultants, this report provides an invaluable insight into the opinions, challenges and opportunities within the Mexican healthcare market.
Areas of coverage include Pharmaceuticals, Biotech, Medical Devices. The report includes contributions from key organisations such as COFEPRIS, CANIFARMA, AMIIF, GSK, Shire, 3M, PwC, Siemens, Silanes, Vitalmex, Smart Scale, DHL, BOMI, and many more
Key topics covered include: the Mexican healthcare system, medical tourism, biosimilars, orphan drugs, private labels, PPP, regulation and law, distribution channels, integrators,and tackling diabetes.